These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1777928)
41. The role of lysolecithin in the relaxation of vascular smooth muscle. Bing RJ; Saeed M Biosci Rep; 1987 Oct; 7(10):783-9. PubMed ID: 3447640 [TBL] [Abstract][Full Text] [Related]
42. Role of nitric oxide and nitric oxide-independent relaxing factor in contraction and relaxation of rabbit blood vessels. Fujimoto S; Itoh T Eur J Pharmacol; 1997 Jul; 330(2-3):177-84. PubMed ID: 9253951 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and pharmacological investigation of some novel 2-methyl-3-(substituted methylamino)-(3H)-quinazolin-4-ones as histamine H1-receptor blockers. Alagarsamy V Pharmazie; 2004 Oct; 59(10):753-5. PubMed ID: 15544052 [TBL] [Abstract][Full Text] [Related]
44. 4-Benzylamino-1-chloro-6-substituted phthalazines: synthesis and inhibitory activity toward phosphodiesterase 5. Watanabe N; Kabasawa Y; Takase Y; Matsukura M; Miyazaki K; Ishihara H; Kodama K; Adachi H J Med Chem; 1998 Aug; 41(18):3367-72. PubMed ID: 9719589 [TBL] [Abstract][Full Text] [Related]
45. Guanidine-annelated heterocycles, VII. Synthesis and antihypertensive activity of 2,10-dimethyl-5H,10H-1,2,4-triazolo [5,1-b]quinazolin-5-one. Liu KC; Hu MK Arch Pharm (Weinheim); 1986 Feb; 319(2):188-9. PubMed ID: 3707300 [No Abstract] [Full Text] [Related]
46. [Synthesis of certain derivatives of 5-methoxy-3-[(benzazole-2-yl) thioacetylamino]-2,3-dihydrobenzofuran and research on their antihypertensive activities]. Turan-Zitouni G; Demirayak S; Erol K; Ozdemir M Ann Pharm Fr; 1996; 54(3):109-11. PubMed ID: 8794579 [TBL] [Abstract][Full Text] [Related]
47. [Synthesis of certain derivatives of methoxy-5-[(benzazole-2-yl)thioacetylamino]-3-dihydro-2,3-benzofuran and research on their antihypertensive activity]. Turan-Zitouni G; Demirayak S; Erol K; Ozdemir M Boll Chim Farm; 1994 Mar; 133(3):148-55. PubMed ID: 8011273 [TBL] [Abstract][Full Text] [Related]
48. [Hypotensive effect of 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino) propane hydrochloride]. Ni XP; Qian JQ; Hu CJ; Xia L; Ni PZ; Mo FZ Zhongguo Yao Li Xue Bao; 1988 Jan; 9(1):64-8. PubMed ID: 3188936 [No Abstract] [Full Text] [Related]
49. Novel 1,4-dihydropyridine calcium antagonists. II. Synthesis and antihypertensive activity of 3-[4-(substituted amino)phenylalkyl]ester derivatives. Ashimori A; Ono T; Inoue Y; Morimoto S; Eda M; Uchida T; Ohtaki Y; Fujino Y; Kido H; Ogura Y Chem Pharm Bull (Tokyo); 1991 Jan; 39(1):91-9. PubMed ID: 2049813 [TBL] [Abstract][Full Text] [Related]
50. New sedative and hypotensive 3-substituted 2,4(1H,3H)-quinazolinediones. Hayao S; Havera HJ; Strycker WG; Leipzig TJ; Kulp RA; Hartzler HE J Med Chem; 1965 Nov; 8(6):807-15. PubMed ID: 5885076 [No Abstract] [Full Text] [Related]
51. Eco-efficient one-pot synthesis of quinazoline-2,4(1H,3H)-diones at room temperature in water. Tian XC; Huang X; Wang D; Gao F Chem Pharm Bull (Tokyo); 2014; 62(8):824-9. PubMed ID: 24920051 [TBL] [Abstract][Full Text] [Related]
52. Vascular relaxation mediated by hydroxylamines and oximes: their conversion to nitrites and mechanism of endothelium dependent vascular relaxation. Thomas G; Ramwell PW Biochem Biophys Res Commun; 1989 Oct; 164(2):889-93. PubMed ID: 2818593 [TBL] [Abstract][Full Text] [Related]
53. [Synthetic studies of substituted quinazolinone]. Eguchi Y; Sugimoto A; Ishikawa M Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1989; 23():65-72. PubMed ID: 2488965 [TBL] [Abstract][Full Text] [Related]
54. Studies on biologically active halogenated compounds. 1. Synthesis and central nervous system depressant activity of 2-(fluoromethyl)-3-aryl-4(3H)-quinazolinone derivatives. Tani J; Yamada Y; Oine T; Ochiai T; Ishida R; Inoue I J Med Chem; 1979 Jan; 22(1):95-9. PubMed ID: 423189 [TBL] [Abstract][Full Text] [Related]
55. The mechanism of cGMP-induced relaxation in vascular smooth muscle. Popescu LM; Panoiu C; Hinescu M; Nutu O Eur J Pharmacol; 1985 Jan; 107(3):393-4. PubMed ID: 2984014 [No Abstract] [Full Text] [Related]
56. Different time course of atrial natriuretic factor-induced relaxation in rabbit aorta and portal vein. De León H; Castañeda-Hernández G; Hong E Eur J Pharmacol; 1990 Jun; 182(1):171-4. PubMed ID: 2144821 [TBL] [Abstract][Full Text] [Related]
57. Nitric oxide mediates the antihypertensive and vascular relaxing effects of a soluble cocoa fiber product in spontaneously hypertensive rats. Fernández Vallinas S; López Carreras N; Miguel M; Aleixandre A Nitric Oxide; 2013 Feb; 29():1-3. PubMed ID: 23142352 [TBL] [Abstract][Full Text] [Related]
58. Synthesis, enantioseparation and pharmacological activity of 4-aryl-7,7-dimethyl-5-oxo-1,2,3,4,5,6,7,8-octahydroquinazoline-2-thiones. Yarim M; Saraç S; Ertan M; Kiliç FS; Erol K Arzneimittelforschung; 2002; 52(1):27-33. PubMed ID: 11838271 [TBL] [Abstract][Full Text] [Related]
59. [Change in the reactions of isolated vascular segments under the action of hypotensive agents]. Kulagina VP; Udel'nov MG Kardiologiia; 1978 Dec; 18(12):94-8. PubMed ID: 732089 [TBL] [Abstract][Full Text] [Related]
60. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent. Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]